Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire

Showing 15 posts of 170 posts found.

cinryze_logo

Shire’s Cinryze gets FDA fast track designation

October 13, 2015
Research and Development AMR, FDA, Shire

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …

News
Shire

Shire ADHD treatment Intuniv gets EU approval

September 21, 2015
Sales and Marketing ADHD, Shire, attention deficit hyperactivity disorder, intuniv

The European Commission has granted marketing authorisation for Shire’s Intuniv for the treatment of ADHD in children.  Intuniv (guanfacine hydrochloride prolonged …

News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015
Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …

News
dun___bradstreet_4efa511357b57

Shire appoints Sara Mathew to board of directors

September 2, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Sara Mathew, Shire

Shire has appointed Sara Mathew to its board of directors as a non-executive director.Mathew will also be a member of …

Appointment
Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015
Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …

News
Shire building

Shire in $300m Foresight acquisition

August 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye

Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …

News
rare_disease_image

Overcoming barriers in rare diseases

June 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, NHS, Shire, bates, government, nps, rare diseases

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

Feature
Actelion image

Shire makes £12 billion move for Actelion

June 8, 2015
Sales and Marketing Actelion, Shire, brett wells, nps pharma

Not a week goes by without a big pharma merger story, and now it’s the turn of Dublin-headquartered Shire that …

News
Shire image

Shire earns EMA nod for constipation drug

June 3, 2015
Sales and Marketing EMA, Resolor, Shire, constipation

Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …

News
jeff_poulton_shire

New chief financial officer for Shire

May 12, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, jeff poulton

Irish pharma firm Shire has appointed a new chief financial officer and member of its executive committee in Jeff Poulton. …

Appointment

Alexion makes $8.4 billion Synageva purchase

May 7, 2015
Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …

News
Shire image

Shire gets FDA boost – but suffers trial setback

April 10, 2015
Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625

Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …

News
Perrigo image

Mylan in huge $29 billion bid for Perrigo

April 9, 2015
Abbott, Mylan, OTC, Perrigo, Shire

Mylan has offered to pay the over-the-counter (OTC) drug specialist Perrigo $28 billion to acquire its business. The proposed deal …

News
Shire image

Shire plots new ADHD drug approval

April 7, 2015
Sales and Marketing ADHD, FDA, SHP465, Shire, Vyvanse, clinical trials, paediatrics

Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …

News
Shire image

Shire to buy Meritage Pharma

February 25, 2015
Research and Development, Sales and Marketing AbbVie, Meritage Pharma, Shire, eoe, gastrointestinal

Shire has purchased Meritage Pharma, a privately-held company specialising in gastrointestinal and skin diseases for $70 million. The acquisition means …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026